Regeneron Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
(technical difficulty)
to Day 2 of the Bank of America Merrill Lynch Conference. My name is Ying Huang and I'm the Large Cap U.S. Biotech Analyst.
I'm very pleased to announce our next presenting company, Regeneron Pharmaceuticals. With us, we have President, CEO and founder, Dr. Len Schleifer; also we have Bob Landry, Chief Financial Officer, with us.
So we're going to use the fireside chat format, and we'll just go into the Q&A.
First of all, let me welcome both Len and Bob to Vegas. Thanks for coming again.
So Ying, let me make some forward-looking statements for those that are on webcast.
We will be making forward-looking statements and it contains risks and uncertainties. Certainly, you can go to our recently filed 10-Q, which outlines all the risks and uncertainties within that disclosure. Okay. Thanks.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |